Shim, Kyu-Sik
Jo, Han-Saem
Kim, Shin Hyun
Kim, Dohyun
Park, Yong-Kyu
Ryu, Da-Hye
Lee, Won-Jai
Roh, Tai-Suk
Baek, Wooyeol https://orcid.org/0000-0002-6638-4110
Funding for this research was provided by:
Ministry of SMEs and Startups (RS-2023-00302877)
Korea/ Israel Industrial Research and Development Foundation (2022-42-196)
Article History
Received: 4 April 2025
Revised: 17 July 2025
Accepted: 7 August 2025
First Online: 28 October 2025
Change Date: 18 March 2026
Change Type: Update
Change Details: The original article has been corrected. Figures 1-3 have been re-ordered.
Change Date: 17 March 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s13770-026-00798-1
Declarations
:
: Kyu-Sik Shim, Han-Saem Jo, Do-Hyun Kim, Yong-Kyu Park and Wooyeol Baek are current employees of PLCOskin Co., Ltd., which manufactures and markets TissueDerm. However, the opinions expressed in this research article were not influenced by the company. The other authors have no conflicts of interest to declare.
: All animal studies were approved by the Institutional Animal Care and Use Committee of Yonsei University College of Medicine (IACUC 2021-0239) and Institutional Animal Care and Use Committee (IACUC) of KTR, by the Animal Protection Act (No. 16977, enforced on February 11, 2020) and the Laboratory Animal Act (No. 15944, enforced on December 11, 2018) (IACUC No. IAC2021-0702).